Carl D. Regillo, MD, FACS, FASRS, discusses geographic atrophy, the advanced stage of dry age-related macular degeneration, including its diagnosis, and progression.
Ocugen, Inc. completes dosing in Phase 2 portion of ArMaDa clinical trial for OCU410
Spotlighting telemedicine in the year of a pandemic
FDA approves amended label for Izervay for geographic atrophy
SeaBeLife announces preclinical efficacy results for SBL03 topical ophthalmic gel
A study of the 3-year clinical outcomes in geographic atrophy
Apellis Pharmaceuticals receives approval of pegcetacoplan (Syfovre) for treatment of geographic atrophy in Australia